NEUBERGER BERMAN GROUP LLC

Position in OCUL — Ocular Therapeutix, Inc

CIK 1465109 NEW YORK, NY

Position in OCUL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$98,848

-$114,462 QoQ

Shares Held

10,066

-80.4% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#199

of 257 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NEUBERGER BERMAN GROUP LLC holds $1,452,567,393 across 97 Biotechnology names. OCUL ranks #70 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	559,445	$277,893,114
2	REGN	Regeneron Pharmaceuticals, Inc.	421,976	$263,118,914
3	TECH	BIO-TECHNE Corp	2,844,692	$200,977,489
4	LGND	Ligand Pharmaceuticals Inc	248,355	$78,502,531
5	CAI	Caris Life Sciences, Inc.	3,590,963	$63,990,960
6	IONS	Ionis Pharmaceuticals Inc	633,533	$50,232,830
7	BBIO	BridgeBio Pharma, Inc.	552,158	$41,124,727
8	INSM	INSMED Inc	378,816	$40,389,361

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$98,848	10,066	-80.4%	Shares	Defined	2026-08-13
2022-09-30	$213,310	51,400	-0.3%	Shares	Defined	2022-11-15
2022-06-30	$207,231	51,550	-14.8%	Shares	Defined	2022-08-15
2022-03-31	$299,524	60,510	-0.1%	Shares	Defined	2022-05-23
2021-12-31	$421,984	60,543	+0.0%	Shares	Defined	2022-02-11
2021-09-30	$605,390	60,539	-1.1%	Shares	Defined	2021-11-12
2021-06-30	$867,660	61,189	-0.6%	Shares	Defined	2021-08-13
2021-03-31	$1,009,854	61,539	-3.2%	Shares	Defined	2021-05-13
2020-12-31	$1,316,313	63,590	+0.2%	Shares	Defined	2021-02-10
2020-09-30	$483,158	63,490	+0.0%	Shares	Defined	2020-11-12
2020-06-30	$528,621	63,460	+0.3%	Shares	Defined	2020-08-13
2020-03-31	$313,038	63,240	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.